New device rapidly controls postpartum hemorrhage
A study led by Columbia obstetricians has shown that a new intrauterine device can rapidly control postpartum hemorrhage, a major cause of severe maternal morbidity and death, in… read more.
A study led by Columbia obstetricians has shown that a new intrauterine device can rapidly control postpartum hemorrhage, a major cause of severe maternal morbidity and death, in… read more.
Seagen Inc. and Genmab A/S announced that the Phase III innovaTV 301 global trial in recurrent or metastatic cervical cancer patients with disease progression on or after front-line… read more.
A nationwide assessment of Obstetrics and Gynecology residency programs reveals the need for more training in how to provide the best care for women going through menopause, according… read more.
The findings are concerning to the researchers, as women may rely on website information to decide whether to have the test. They also may make decisions or plans… read more.
Experts at UCL have teamed up with leading women’s health charities to design a new education and support programme for women across the country experiencing menopause. The National… read more.
Emergency contraception treatment with levonorgestrel plus piroxicam is significantly more effective than levonorgestrel monotherapy, researchers reported on August 16, 2023 in the Lancet. “Overall, this study suggests that… read more.
Despite the fact that nearly 90 million women in the United States are projected to be postmenopausal by 2060, menopause remains low on the priority list of many… read more.
The quality of life of millions suffering from endometriosis – a painful disease where sensitive tissue grows outside of the uterus – could be improved by a new… read more.
Despite advances in surgery and chemotherapy, survival of people with certain types of ovarian cancer has not significantly changed in decades. That has meant that some ovarian cancer… read more.
Amid widely differing capacities of available menstrual hygiene products, a menstrual disc—similar in shape to a diaphragm—may be best for dealing with heavy monthly blood flow as well… read more.
Sage Therapeutics, Inc .and Biogen Inc. announced the FDA approved Zurzuvae (zuranolone) 50 mg for adults with postpartum depression (PPD). Zurzuvae is the first and only oral, once-daily,… read more.
Smoking in pregnancy can harm developing babies, especially their growth . Current guidelines recommend that pregnant smokers who find quitting difficult should be provided with nicotine replacements products and… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.